Jump to:

Orodispersible Levitra tablet launched for ED

04 May 2011, 9:26am

Levitra is the first ED drug to be launched as an orodispersible formulation

Levitra is the first ED drug to be launched as an orodispersible formulation

Erectile dysfunction treatment vardenafil (Levitra) is now available as an orodispersible tablet.

Placed on the tongue approximately 60 minutes before sexual activity, the 10mg tablet rapidly dissolves without the need to take separate liquid.

Efficacy of the orodispersible tablet was demonstrated in two 12-week studies of identical design, POTENT I and POTENT II.

The 2 studies enrolled a total of 882 men who had had erectile dysfunction for more than 6 months. In both studies, the orodispersible tablets were significantly superior to placebo for all efficacy measures (p<0.0001 for all), both primary (International Index of Erectile Function and Sexual Encounter Profile questions 2 and 3) and secondary.

Levitra orodispersible tablets are not indicated for initiation of vardenafil treatment in patients with mild hepatic impairment.

View Levitra drug record

Further information: Bayer

 

MIMS Specialist Journals

Now available on www.mims.co.uk

Click here to view

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

NICE Guidance: IBS

NICE Guidance: IBS

MIMS Summary of
NICE guideline

NICE Guidance: Lipid Modification

NICE Guidance: Lipid Modification

MIMS Summary of
NICE guideline

Quick-reference table: antibiotics

Quick-reference table: antibiotics

Treatment regimens for common infections

Referral Guidelines for Breast Disorders

Referral Guidelines for Breast Disorders

MIMS Summary of NHS Cancer Screening Referral Guidelines

Back to top